Immuneering Corp (IMRX) Executive Compensation
Immuneering Corp (IMRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IMRX
CIK: 1790340
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
RSM US LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerKaitlin Folinus
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001790340-26-000091 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001790340-26-000088 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-28 | — | SCHEDULE 13G Filing | 0002012383-26-002523 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-16 | FORM 4 | 0001790340-26-000082 | View SEC Doc Filr Page |
| 3 | 2026-07-16 | 2026-07-16 | FORM 3 | 0001790340-26-000080 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-23 | FORM 4 | 0001790340-26-000078 | View SEC Doc Filr Page |
| 4 | 2026-06-16 | 2026-06-15 | FORM 4 | 0001790340-26-000076 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-11 | 8-K | 0001790340-26-000074 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-11 | FORM 4 | 0001790340-26-000072 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-11 | FORM 4 | 0001790340-26-000070 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-11 | FORM 4 | 0001790340-26-000068 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-11 | FORM 4 | 0001790340-26-000066 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-11 | FORM 4 | 0001790340-26-000064 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-11 | 8-K | 0001790340-26-000062 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-06-01 | 8-K | 0001790340-26-000059 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001790340-26-000057 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | 8-K | 0001790340-26-000055 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-20 | — | DEFA14A | 0001790340-26-000050 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-20 | 2026-04-20 | DEF 14A | 0001790340-26-000048 | View SEC Doc Filr Page |
| 4 | 2026-03-17 | 2026-03-13 | FORM 4 | 0001790340-26-000044 | View SEC Doc Filr Page |
| 10-K | 2026-03-06 | 2025-12-31 | 10-K | 0001790340-26-000042 | View SEC Doc Filr Page |
| 8-K | 2026-03-06 | 2026-03-06 | 8-K | 0001790340-26-000040 | View SEC Doc Filr Page |
| 4 | 2026-02-05 | 2026-02-03 | FORM 4 | 0001790340-26-000034 | View SEC Doc Filr Page |
| 4 | 2026-02-05 | 2026-02-03 | FORM 4 | 0001790340-26-000032 | View SEC Doc Filr Page |
| 4 | 2026-02-05 | 2026-02-03 | FORM 4 | 0001790340-26-000030 | View SEC Doc Filr Page |